Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucophage SR in type 2 diabetes with moderate chronic kidney disease
ISRCTN70770260Phase 2Completed
- Sponsor
- Glangwili General Hospital
- Start
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Glucophage SR arm with Placebo arm (2 arms). Primary endpoint: Change in HbA1c from baseline to end of study. Started May 2012; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN70770260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70770260.